These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7204716)

  • 21. Vancomycin.
    Geraci JE
    Mayo Clin Proc; 1977 Oct; 52(10):631-4. PubMed ID: 909314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis.
    Ayus JC; Eneas JF; Tong TG; Benowitz NL; Schoenfeld PY; Hadley KL; Becker CE; Humphreys MH
    Clin Nephrol; 1979 Mar; 11(3):129-32. PubMed ID: 436339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vancomycin therapy for methicillin-resistant Staphylococcus aureus.
    Sorrell TC; Packham DR; Shanker S; Foldes M; Munro R
    Ann Intern Med; 1982 Sep; 97(3):344-50. PubMed ID: 7114631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD).
    Wilson FP; Berns JS
    Clin Nephrol; 2012 Apr; 77(4):329-31. PubMed ID: 22445477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Optimal vancomycin serum level in Staphylococcus aureus infections?].
    Bingen E; Mariani-Kurkdjian P; Nebbad B
    Med Mal Infect; 2006 Sep; 36(9):439-42. PubMed ID: 17027219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous vancomycin as initial treatment for gram-positive peritonitis in patients on chronic peritoneal dialysis.
    Obermiller LE; Tzamaloukas AH; Leymon P; Avasthi PS
    Clin Nephrol; 1985 Nov; 24(5):256-60. PubMed ID: 3907908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Endocarditis in hemodialysis and prognosis].
    de Lorenzo A; Bernis C; Diego G; Sánchez Tomero JA
    Nefrologia; 2006; 26(6):749-50. PubMed ID: 17227258
    [No Abstract]   [Full Text] [Related]  

  • 29. Staphylococcus aureus infection of dialysis shunt: absence of synergy with vancomycin and rifampin.
    Tofte RW; Solliday J; Rotschafer J; Crossley KB
    South Med J; 1981 May; 74(5):612-5. PubMed ID: 7244722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vancomycin hemodialysis: Clearance differences between high-flux hemodialysis and on-line hemodiafiltration.
    Rodríguez N; Gómez M; Rico N; María Campistol J; Maduell F
    Artif Organs; 2019 Mar; 43(3):261-269. PubMed ID: 30302764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infective endocarditis: a frequent disease in dialysis patients.
    Hoen B
    Nephrol Dial Transplant; 2004 Jun; 19(6):1360-2. PubMed ID: 15004259
    [No Abstract]   [Full Text] [Related]  

  • 32. [Staphylococcal bacteremias in patients maintained on chronic hemodialysis].
    Vilardell J; Caralps A; Andreu J; Brulles A; Sola R; Ricart MJ; Oppenheimer F; Esteller E; Sans A; Andreu J
    Rev Clin Esp; 1983 Jul 15-31; 170(1-2):41-3. PubMed ID: 6635276
    [No Abstract]   [Full Text] [Related]  

  • 33. Association of bacterial genotypes and epidemiological features with treatment failure in hemodialysis patients with methicillin-resistant Staphylococcus aureus bacteremia.
    Lin SY; Tu HP; Chen TC; Shen MC; Chiu YW; Chen YH; Lu PL
    PLoS One; 2018; 13(6):e0198486. PubMed ID: 29864149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.
    Stryjewski ME; Szczech LA; Benjamin DK; Inrig JK; Kanafani ZA; Engemann JJ; Chu VH; Joyce MJ; Reller LB; Corey GR; Fowler VG
    Clin Infect Dis; 2007 Jan; 44(2):190-6. PubMed ID: 17173215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced clearance of vancomycin by hemodialysis in a child.
    Schoumacher R; Chevalier RL; Gomez RA; Rogol AD; Cummings R; Spyker DA
    Pediatr Nephrol; 1989 Jan; 3(1):83-5. PubMed ID: 2702093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Falsely elevated serum vancomycin concentrations in hemodialysis patients.
    Follin SL; Mueller BA; Scott MK; Carfagna MA; Kraus MA
    Am J Kidney Dis; 1996 Jan; 27(1):67-74. PubMed ID: 8546140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limitations of vancomycin in the management of resistant staphylococcal infections.
    Kollef MH
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S191-5. PubMed ID: 17712746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin during the Last Hour of the Hemodialysis Session: A Pharmacokinetic Analysis.
    Ghouti-Terki L; Chasseuil E; Rabot N; Paintaud G; François M; Birmelé B; Darrouzain F; Büchler M; Halimi JM; Ternant D
    Nephron; 2017; 135(4):261-267. PubMed ID: 28152540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute Kidney Injury Associated With Vancomycin When Laxity Leads to Injury and Findings on Kidney Biopsy.
    Katikaneni M; Lwin L; Villanueva H; Yoo J
    Am J Ther; 2016; 23(4):e1064-7. PubMed ID: 26035034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration.
    De Bock V; Verbeelen D; Maes V; Sennesael J
    Nephrol Dial Transplant; 1989; 4(7):635-9. PubMed ID: 2510061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.